Fluo Labs, LLC

Fluo Labs is a medical device company that uses light therapeutics to help alleviate the symptoms of hay fever. We are developing a breakthrough device that promises to dramatically improve the way people manage allergic rhinitis.

The new device will be affordable, easy-to-use and provides drug-free rapid relief with no known side effects. Created by a team of experts in the fields of light therapeutics, antihistamines, and nasal steroids, the Fluo is the result of several years of cutting-edge research, preclinical and clinical development. Fluo Labs has two additional clinical trials planned and is pursuing FDA approval for the use of the Fluo as an OTC device. The Fluo is expected to be available for purchase in early 2022.

Allergic Rhinitis (AR) causes a wide variety of misery-inducing symptoms such as sneezing, congestion, runny nose, itchy and watery eyes, headaches and fatigue. To add insult to injury, climate change has lengthened the average allergy season. To treat AR symptoms, many people turn to over-the-counter allergy medications or immunotherapy. While these medications work for many people, they may not be the right solution for everyone and carry the added risk of side effects.

The Fluo treats AR through a light therapy known as photobiomodulation. Used by the medical community for pain relief, inflammation reduction, wound healing and tissue regeneration, photobiomodulation operates a beneficial photochemical effect where light engenders a chemical change as it is absorbed by the body’s tissue.

The Fluo will provide welcome relief to the millions of allergy sufferers around the world, especially for those who don’t want to or cannot take medication due to contraindications, pregnancy, heart or thyroid conditions and job restrictions.

For consumers who are seeking non-drug solutions, there has been no single natural remedy that can provide efficient symptom relief in a convenient treatment – until now.

Company’s Keywords: